![](/images/Email.png)
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
University of Washington Through its Center for Commercialization
US Patent
University of Washington Through its Center for Commercialization
US Patent
Affinity DataIC50: 177nMAssay Description:Inhibition of human tyrosine kinases.More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
University of Washington Through its Center for Commercialization
US Patent
University of Washington Through its Center for Commercialization
US Patent
Affinity DataIC50: 177nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
University of Washington Through its Center for Commercialization
US Patent
University of Washington Through its Center for Commercialization
US Patent
Affinity DataIC50: 180nMAssay Description:Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphorimaging methodMore data for this Ligand-Target Pair
![](/img/powered_by_small.gif)